Splitting a Stock Price Into Its Two Claims
Every traded price bundles two claims: the earnings stream the existing business already produces, and the option on projects management has not started yet. PVGO makes the split explicit — price equals no-growth value plus the present value of growth opportunities. On the default inputs of an $80 stock with $4 of forward EPS and a 9% cost of equity, the existing business is worth $44.44, and the remaining $35.56, or 44.4% of the price, is payment for growth.
The no-growth half capitalizes next-year earnings as a level perpetuity using the same logic as a present value calculator: E divided by r. A firm earning $4 per share with a 9% required return is worth $44.44 if it never grows another dollar. That figure is the anchor for everything downstream, and it moves one-for-one with your discount rate assumption.
The growth half is a residual, so it inherits every error in your inputs. Raising r from 7% to 12% on the same $80 stock with $4 EPS swings the implied growth share from 28.6% to 58.3% without a single change at the company. Treat PVGO as a decomposition of your own assumptions, and let the sensitivity — not one headline number — drive conclusions.
The Justified PVGO Formula
Market-implied PVGO tells you what investors are paying for growth. Justified PVGO tells you what reinvestment can actually deliver: retention x EPS x (ROE - r) divided by r x (r - g), where g equals retention x ROE. The spread between ROE and the cost of equity — never growth by itself — is the value engine. Growth funded at returns below r compounds revenue while destroying per-share value.
At the defaults of 40% retention and 12% ROE, g runs at 4.8% and justified PVGO lands at $12.70 against the $35.56 the market charges. The identity holds exactly: no-growth $44.44 plus justified $12.70 equals $57.14, which is the same value produced by a dividend discount model calculator using E x (1 - b) over (r - g). PVGO and the DDM are one framework seen from two angles.
When ROE drops below the cost of equity, the justified term turns negative. The bank example — 60% retention, 9% ROE against an 11% cost of equity — prices reinvestment at -$11.69 per share while the market pays +$5.45 for growth, a $17.14 disagreement. Shareholders in that scenario would be better off with a full payout, a case you can size with a dividend payout ratio calculator.
Reading the Gap Between Market and Justified
Three outcomes matter. Justified above market-implied means the growth premium looks cheap: a $100 stock with $3 EPS, an 8% cost of equity, 50% retention and 14% ROE carries a justified PVGO of $112.50 against the $62.50 the market charges, a $50 gap in the investor's favor. Roughly equal means the price and your reinvestment assumptions tell the same story.
Market-implied above justified is the case that demands scrutiny, because the excess premium needs an explanation your inputs do not supply — a bigger opportunity set, a longer competitive advantage period, or rising returns on capital. The default inputs sit here: $35.56 implied against $12.70 justified, meaning the market pays nearly three times what steady-state reinvestment math supports.
One special case breaks the tool honestly. A firm retaining 70% of earnings at a 25% ROE compounds at 17.5%, past a 10% cost of equity, and the single-stage denominator collapses. The calculator reports undefined rather than a fantasy number. That guard is information: durable excess returns of that size need a multi-stage model with an explicit fade, and any single formula claiming to value them is lying.
PVGO and the P/E Multiple
The decomposition rewrites a familiar multiple: P/E equals 1/r plus PVGO divided by E. On the defaults, the 20.0x actual multiple splits into an 11.1x no-growth floor plus 8.9 turns contributed by growth. A price to earnings calculator reports the headline; PVGO shows which fraction of it the existing business actually underwrites.
The no-growth floor depends only on r: 14.3x at 7%, 12.5x at 8%, 11.1x at 9%, 10.0x at 10%, 9.1x at 11% and 8.3x at 12%. Utilities cluster near their floor because reinvestment there earns barely above the cost of capital — the worked utility example produces a PVGO of exactly $0.00 on a 12.5x multiple. Multiples far above the floor are, definitionally, growth claims.
Two stocks with identical 20x multiples can carry opposite risk profiles: one earning 20% on new capital with justified growth value to spare, another reinvesting below its cost of equity with a negative justified term. Ratio tools like a PEG ratio calculator compress that difference away, which is exactly the information a dollar-denominated split preserves.
Negative PVGO and the Deep-Value Signal
A $30 stock with $4 of expected EPS at a 10% cost of equity shows a no-growth value of $40 and a PVGO of -$10, or -33.3% of price. The market pays less than the un-growable earnings stream is worth. Classic explanations include expected secular decline, chronic over-retention at low returns, or simple capitulation pricing where nobody models the earnings power anymore.
Negative PVGO is a starting point for research, never a verdict. Sometimes the market is right and earnings are about to fall. Sometimes trough cyclicality crushes trailing EPS and the forward figure a Graham number calculator or an intrinsic value calculator would use tells a very different story from the depressed market quote.
Accounting quality matters most in this zone. Buybacks shrink book equity and distort trailing ROE; impairments or one-off charges can make forward EPS unrepresentative; clean-surplus violations break the retention-to-growth link the justified formula assumes. When the inputs are noisy, the honest output is a range — run the split at a low and a high EPS and see whether the PVGO share even keeps its sign.
Choosing the Cost of Equity
No input works harder than r. The CAPM route — a 4.2% risk-free rate plus 1.15 beta times a 5% equity risk premium — yields 9.95%, and a CAPM calculator produces that figure directly. For consistent payers, the dividend growth model offers a cross-check, and a dedicated cost of equity calculator reconciles the two methods when they disagree.
The mechanical direction matters when you move r. A higher discount rate shrinks the no-growth floor — $4 of EPS is worth $57.14 at 7% but only $33.33 at 12% — which mechanically inflates the residual PVGO on a fixed price. The growth share of an unchanged $80 stock climbs from 28.6% to 58.3% purely from the rate move, before any company news.
That asymmetry is why rate scares hit growth-heavy names twice: the floor drops and the required return rises at the same time. Stress-testing r by a full point in each direction is the cheapest robustness check in valuation. If your conclusion flips between 8% and 10%, the stock is a bet on the discount rate, and you should know that before owning it.
Worked Examples Across Sectors
The utility case is the textbook: a $55 stock with $4.40 EPS, an 8% cost of equity, 20% retention and 9% ROE produces a no-growth value of exactly $55.00 and a market PVGO of $0.00, with a justified figure of just $1.77. The 12.5x multiple equals the no-growth floor to the decimal. Nothing in that price pays for growth, and nothing needs to.
The bank case shows value destruction hiding inside a modest multiple: a $60 stock at 10x with $6 EPS and an 11% cost of equity has a market PVGO of only $5.45, yet justified PVGO runs at -$11.69 because 60% retention at 9% ROE sits two points below the cost of equity. The DDM cross-check values that policy at $42.86 versus the $54.55 no-growth alternative, an $11.69 per-share haircut created by reinvesting below the cost of equity.
The growth case shows the opposite: justified $112.50 against a $62.50 market premium makes the 62.5% growth share cheap, provided the 14% ROE assumption survives contact with competition. Building the EPS input for cases like this is easier with an EPS growth calculator, which projects the earnings path your retention assumptions imply.
Where PVGO Fits in a Valuation Stack
PVGO earns its place as a diagnosis layer between absolute-value and relative-value tools. Run a DCF or DDM for the target price, multiples for the market context, then PVGO to answer the question those tools skip: how much of this price is a claim on the future? A 44% growth share demands better forecasting humility than a 5% share, whatever the valuation verdict.
A practical workflow reads: estimate r through CAPM, pull consensus forward EPS, read retention and incremental ROE from the last few annual reports, then run the split and compare implied against justified. The whole exercise takes ten minutes and consistently surfaces the hidden assumption — the ROE spread — that decides whether a growth story compounds or bleeds.
Know the failure modes before trusting the output. Current-loss companies need a normal-year EPS to run at all; financial firms distort book ROE through leverage; and any case where retention x ROE meets r belongs in a multi-stage model, not a perpetuity. Used within those limits, the PVGO share is one of the sharpest available gauges of how much story you are buying with each share.